BALYASNY ASSET MANAGEMENT L.P. - INNATE PHARMA S A ownership

Back to all holdings Add to watchlist

INNATE PHARMA S A's ticker is IPHA and the CUSIP is 45781K204. A total of 13 filers reported holding INNATE PHARMA S A in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Links
Filings
External links
Quarter-by-quarter ownership
BALYASNY ASSET MANAGEMENT L.P. ownership history of INNATE PHARMA S A
ValueSharesWeighting
Q3 2022$32,000
-97.2%
16,094
-91.4%
0.00%
-100.0%
Q3 2021$1,157,000–187,484–0.01%–
 Download
Other shareholders
INNATE PHARMA S A shareholders Q3 2022
NameSharesValueWeighting ↓
EXCHANGE TRADED CONCEPTS, LLC 34,998$88,5450.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
MILLENNIUM MANAGEMENT LLC 46,973$118,8420.00%
MORGAN STANLEY 44,954$113,7340.00%
Steward Partners Investment Advisory, LLC 500$1,2650.00%
Optiver Holding B.V. 190,219$481,2540.00%
BARCLAYS PLC 412$10.00%
UBS Group AG 146$3690.00%
RHUMBLINE ADVISERS 205$5180.00%
View complete list of INNATE PHARMA S A shareholders